Management of otitis media in the era of managed care.
Klein
J O
JO
Boston University School of Medicine, Massachusetts, USA.
Bluestone
C D
CD
D000233:Adenoidectomy; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004358:Drug Therapy / Q000191:economics; D004777:Environment; D006311:Hearing Disorders / Q000175:diagnosis / Q000191:economics; D006320:Hearing Tests / Q000191:economics; D006801:Humans; D007114:Immunization; D007223:Infant; D008329:Managed Care Programs / Q000191:economics*; D008876:Middle Ear Ventilation; D009225:Myringoplasty; D009819:Office Visits / Q000191:economics; D010033:Otitis Media / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D010034:Otitis Media with Effusion / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000628:therapy; D010353:Patient Education as Topic; D012008:Recurrence; D012307:Risk Factors; D016896:Treatment Outcome; D014432:Tympanic Membrane / Q000601:surgery
D000900:Anti-Bacterial Agents